Pathology Testing Services for HFE Genes
A Contract Award Notice
by BETSI CADWALADR UNIVERSITY HEALTH BOARD
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £47K
- Sector
- HEALTH
- Published
- 17 Jul 2026
- Delivery
- not specified
- Deadline
- n/a
Related Terms
Location
Betsi Cadwaladr University Health Board
2 buyers
1 supplier
- Randox Laboratories Crumiln
Description
Betsi Cadwaladr University Health Board intends to award a contract to a provider under the Most Suitable Provider Process for the provision of Pathology Testing Services for HFE Genes including extraction
Total Quantity or Scope
This is a Provider Selection Regime (PSR) Intention to Award Notice. Betsi Cadwaladr University Health Board (BCUHB) intends to to award a contract under the Most Suitable Provider Process under The Health Services (Provider Selection Regime) (Wales) Regulations 2025 for the provision of outsourced pathology testing services for HFE genes, including sample extraction. In accordance with the Most Suitable Provider Process, the Contracting Authority has considered which providers are capable of delivering the service and, having regard to the key criteria and all relevant information available at this time, considers that it has identified the most suitable provider to deliver the requirement. The Contracting Authority intends to award a single contract to the most suitable provider. This Intention to Award Notice will be published for a period of at least 8 days.
Award Detail
| 1 | Randox Laboratories (Crumiln)
|
Award Criteria
| PRICE | _ |
CPV Codes
- 85111800 - Pathology services
- 85111810 - Blood analysis services
Indicators
- Award on basis of price.
Other Information
This is a Provider Selection Regime (PSR) Intention to Award a Contract Notice. The contract is subject to The Health Services (Provider Selection Regime) (Wales) Regulations 2025 and is intended to be awarded using the Most Suitable Provider Process. (WA Ref:167994)
Reference
- FTS 067988-2026